NCT06005454

The Impact of Fish Oil Supplementation on the Outcome of Children with Pneumonia I

The Impact of Fish Oil Supplementation on the Outcome of Children with Pneumonia in the Intensive Care Unit

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 122 (actual)
• Sponsor: Cairo University · Academic / Other
• Sex: All
• Age: 1 Month – 5 Years
• Healthy volunteers: Accepted

Summary

The aim of study is to investigate the effect of enteral feeding of Omega-3 on the outcome of children with Pneumonia in PICU

Detailed description

Group A(cases) will be supplemented by omega-3 fatty acids for immediate post admission consecutive 7 days besides conventional treatment of pneumonia, in a dose of 350 mg twice daily for children less than 3 years and 450 mg twice daily for older children according to the standard treatment per the American Institute of Medicine of the National Academies guidelines for maximum dose for this age group. (Institute of Medicine of the National Academies,2016) Side effects of omega-3 supplements are usually mild. They include unpleasant taste, bad breath, bad-smelling sweat, headache, and gastrointestinal symptoms such as heartburn, nausea, and diarrhea. (Office of Dietary Supplements ,2016) Group B(controls) will be received enteral feeding without omega-3 fatty acid support.

Conditions

• Pneumonia

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Fish oil (Omega)	We will use a dietary supplement source of omega 3 fatty acids from the available syrup ( each 5 ml contain 640 mg of high DHA Fish oil) so we will give it in a dose 2.7 ml twice daily for children between 1 and 3 years and 3.5 ml twice daily for children between 4 and 5 years.

Timeline

• Start date: 2023-09-01
• Primary completion: 2024-09-11
• Completion: 2024-10-11
• First posted: 2023-08-22
• Last updated: 2025-03-19

Locations

1 site across 1 country: Egypt